The following abstracts are from the DIA “Quality of Life Evaluation” workshop, held April 26–27, 1993 in Charleston, South Carolina. Readers who are interested in further information on any of the papers abstracted should contact the DIA office by mail, fax, or phone: Drug Information Association, P.O. Box 3113, Maple Glen, PA 19002, USA—FAX: 215/641–1229—Phone 215/628–2288.
Get full access to this article
View all access options for this article.
References
1.
JuniperEFGuyattGHDevelopment and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21: 77–83.
2.
GuyattGHA measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42: 773–778.
3.
JuniperEFGuyattGHEpsteinRSEvaluation of impairment of health related quality of life in asthma: Development of a questionnaire for use in clinical trials. Thorax. 1992;47: 76–83.
